Merck & Co., Inc. — Director's Dealing 2017

Apr 10, 2017

SEC Form 4/A — Form 4/A

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-02-27

Reporting Person: Schechter Adam H (EVP & Pres-Global Human Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-27	Common Stock	A	37758.0000	$65.8500	Acquired	37758.0000	Direct

Footnotes

F1: The Amended Form 4 is being filed to correct an administrative error with regard to the number of shares withheld for payment of taxes on the 2/27/17 vesting of performance share units. The number of securities beneficially owned following the reported transaction should have been reported as 37,758.0000, and includes shares acquired in dividend reinvestment transactions.